Last year, Twist Bioscience Corp generated 208.10M USD for its biggest-performing segment, NGS tools. The Americas made the largest contribution, accounting for 225.58M USD last year. For the latest quarter, Twist Bioscience Corp reported the revenue of 61.80M USD for the period ending 2026-06-30, which came from the top-performing segment, NGS applications. Americas contributed the highest revenue, at 77.26M USD.